Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer.
Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dose de-escalation to the norm ...... come for T1/T2 glottic cancer.
@en
Dose de-escalation to the norm ...... come for T1/T2 glottic cancer.
@nl
type
label
Dose de-escalation to the norm ...... come for T1/T2 glottic cancer.
@en
Dose de-escalation to the norm ...... come for T1/T2 glottic cancer.
@nl
prefLabel
Dose de-escalation to the norm ...... come for T1/T2 glottic cancer.
@en
Dose de-escalation to the norm ...... come for T1/T2 glottic cancer.
@nl
P2860
P1433
P1476
Dose de-escalation to the norm ...... tcome for T1/T2 glottic cancer
@en
P2093
Hong-Shik Choi
Hyung Kwon Byeon
P2860
P2888
P356
10.1038/S41598-017-15974-6
P407
P577
2017-11-16T00:00:00Z